Social Media Ideas for Acute Myeloid Leukemia

Immune Cells Employ Novel Pathway to Eliminate Acute Myeloid Leukemia

T cells may be able to kill acute myeloid leukemia (AML) through an unexpected route that bypasses the usual way tumors are “seen.” Researchers at The University of Texas MD Anders...

Could engaging the immune system improve AML outcomes?

With unmet need still high in AML, new approaches are exploring whether engaging immune responses could help improve long-term disease control.

Genomic and Epigenomic Insights into Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL), a malignancy of the lymphoid progenitor cells, has long been a focus of intense biomedical research due to its aggressive nature and prevalence...

Novel Epigenetic Therapy Targets Treatment-Resistant and TP53-Mutant AML

The results of a preclinical study across multiple models of acute myeloid leukemia found that the investigational hypomethylating agent, NTX-301 remained effective in treatment-re...

Mesutoclax points to possible shift in high-risk MDS and AML

Early ASCO 2026 data show strong responses and improved safety with mesutoclax in high-risk MDS and AML. Hear what it may mean for treatment.

Epigenomic Analysis Uncovers New AML Subgroups and Drug Sensitivities

New chromatin‑based analysis of 1,563 AML samples reveals 16 epigenomic subgroups that improve prognostic accuracy and highlight unexpected drug sensitivities. The post Epigenomic...

急性骨髄性白血病の「個性」16分類　エピゲノムに注目　京都大

Two-Pill Combo Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML

FRIDAY, June 5, 2026 — An already available two-pill combo treats leukemia just as well as IV drugs, which should make cancer treatment easier on older adults, a new clinical tria...

Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy

Indiana University School of Medicine cancer researchers have identified a potential way to use existing, accessible drugs to combat juvenile myelomonocytic leukemia (JMML) by targ...